J&J Is Making Covid Vaccine on a Not-for-Profit Basis

The transcript discusses the role of public-private partnerships in accelerating vaccine development, highlighting the importance of government funding and collaboration between regulators and scientists. Johnson & Johnson emphasizes their commitment to providing vaccines on a not-for-profit basis to ensure global access.

What is the main reason the government provides financial support to companies for vaccine development?

• To ensure companies make a profit

• To accelerate the production and availability of vaccines

• To reduce the cost of healthcare

• To control the vaccine market

How do public-private partnerships benefit vaccine development?

• They limit the involvement of scientists

• They facilitate advancements and speed up timelines

• They slow down the regulatory process

• They increase competition among companies

What role do regulators and scientists play in public-private partnerships?

• They have no significant role

• They compete against each other

• They focus solely on profit

• They work together to ensure safety and efficacy

What is Johnson & Johnson's approach to vaccine distribution during the pandemic?

• To sell vaccines at a high price

• To distribute vaccines on a not-for-profit basis

• To limit vaccine access to certain countries

• To prioritize profit over public health

Why is it important for Johnson & Johnson to provide vaccines on a not-for-profit basis?

• To ensure as many people as possible have access to vaccines

• To compete with other healthcare companies

• To increase their market share

• To reduce production costs